Related Experiment Video
Updated: May 17, 2026

Generalized Psychophysiological Interaction (PPI) Analysis of Memory Related Connectivity in Individuals at Genetic Risk for Alzheimer's Disease
Published on: November 14, 2017
Association between Alzheimer's Disease and Apolipoprotein E Polymorphisms.
E Gozalpour1, K Kamali, K Mohammd
1Genetic Research Centre, University of Social Welfare and Rehabilitation Sciences, Tehran, Iran.
The APOE ε4 allele significantly increases Alzheimer's disease risk in the Iranian population, with carriers developing AD 6.5 times more often than non-carriers. Male carriers face a higher risk than female carriers.
Area of Science:
- Genetics
- Neuroscience
- Epidemiology
Background:
- Alzheimer's disease (AD) is the most common dementia, a neurodegenerative disorder.
- Genetic factors, including Apolipoprotein E (APOE) genotypes, influence AD susceptibility.
- The APOE ε4 allele is a known risk factor for late-onset AD.
Purpose of the Study:
- To investigate the association between APOE genotypes and alleles with Alzheimer's disease in the Iranian population.
- To determine the frequency of APOE genotypes and alleles in AD cases and control subjects.
Main Methods:
- Genotyping of APOE in 154 AD cases and 162 controls from Iran using PCR.
- Comparison of genotype and allele frequencies between cases and controls.
- Statistical analysis using chi-squared or Fisher's exact test.
Main Results:
- The APOE ε2ε3 genotype was more frequent in controls (13.5%) than in AD cases (5.2%).
- The APOE ε3ε4 genotype was significantly more frequent in AD cases compared to controls.
- APOE ε2 allele frequency was lower in cases but not significantly different from controls.
Conclusions:
- Carrying the APOE ε4 allele increases the risk of developing AD by approximately 6.5 times.
- The risk associated with the APOE ε4 allele appears higher in males than in females.
- Findings highlight the role of APOE ε4 in AD pathogenesis within the Iranian population.
More Related Videos
07:08A High Throughput, Multiplexed and Targeted Proteomic CSF Assay to Quantify Neurodegenerative Biomarkers and Apolipoprotein E Isoforms Status
Published on: October 20, 2016
09:45Motor and Hippocampal Dependent Spatial Learning and Reference Memory Assessment in a Transgenic Rat Model of Alzheimer's Disease with Stroke
Published on: March 22, 2016
Related Concept Videos
Alzheimer Disease l: Introduction
Alzheimer's Disease: Overview
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
Alzheimer Disease ll: Pathophysiology
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase
Alzheimer's Disease: Treatment
Dementia l: Introduction